List of Tables
Table 1. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Voriconazole
Table 3. Key Players of Liposomal Amphotericin B
Table 4. Key Players of Systemic Oral Azoles
Table 5. Key Players of Topical Antifungal Agents
Table 6. Key Players of Others
Table 7. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2020-2025)
Table 11. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2026-2031)
Table 13. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Trends
Table 14. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Drivers
Table 15. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Challenges
Table 16. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Restraints
Table 17. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Players (2020-2025)
Table 19. Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment as of 2024)
Table 20. Ranking of Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Headquarters and Area Served
Table 23. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Product and Application
Table 24. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Basilea Pharmaceutica Company Details
Table 50. Basilea Pharmaceutica Business Overview
Table 51. Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 52. Basilea Pharmaceutica Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 53. Basilea Pharmaceutica Recent Development
Table 54. Astellas Pharma Company Details
Table 55. Astellas Pharma Business Overview
Table 56. Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 57. Astellas Pharma Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 58. Astellas Pharma Recent Development
Table 59. Ferrer International Company Details
Table 60. Ferrer International Business Overview
Table 61. Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 62. Ferrer International Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 63. Ferrer International Recent Development
Table 64. Pacgen Life Science Company Details
Table 65. Pacgen Life Science Business Overview
Table 66. Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 67. Pacgen Life Science Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 68. Pacgen Life Science Recent Development
Table 69. NovaDigm Therapeutics Company Details
Table 70. NovaDigm Therapeutics Business Overview
Table 71. NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 72. NovaDigm Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 73. NovaDigm Therapeutics Recent Development
Table 74. Cidara Therapeutics Company Details
Table 75. Cidara Therapeutics Business Overview
Table 76. Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 77. Cidara Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 78. Cidara Therapeutics Recent Development
Table 79. Amplyx Pharmaceuticals Company Details
Table 80. Amplyx Pharmaceuticals Business Overview
Table 81. Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 82. Amplyx Pharmaceuticals Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 83. Amplyx Pharmaceuticals Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 87. Pfizer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 92. Novartis Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 97. Sanofi Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 98. Sanofi Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 102. Merck Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 103. Merck Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 107. Bayer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 108. Bayer Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 112. GlaxoSmithKline Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 117. Abbott Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 118. Abbott Recent Development
Table 119. Cipla Company Details
Table 120. Cipla Business Overview
Table 121. Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 122. Cipla Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 123. Cipla Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Systemic Aspergillosis and Systemic Candidiasis Treatment Picture
Figure 2. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Voriconazole Features
Figure 5. Liposomal Amphotericin B Features
Figure 6. Systemic Oral Azoles Features
Figure 7. Topical Antifungal Agents Features
Figure 8. Others Features
Figure 9. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Application: 2024 VS 2031
Figure 11. Chronic Pulmonary Aspergillosis (CPA) Case Studies
Figure 12. Allergic Bronchopulmonary Aspergillosis (ABPA) Case Studies
Figure 13. Gastrointestinal Candidiasis Case Studies
Figure 14. Genitourinary Tract Candidiasis Case Studies
Figure 15. Others Case Studies
Figure 16. Systemic Aspergillosis and Systemic Candidiasis Treatment Report Years Considered
Figure 17. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Players in 2024
Figure 21. Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in 2024
Figure 23. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 25. United States Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 29. Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2020-2031)
Figure 37. China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Basilea Pharmaceutica Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 53. Astellas Pharma Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 54. Ferrer International Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 55. Pacgen Life Science Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 56. NovaDigm Therapeutics Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 57. Cidara Therapeutics Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 58. Amplyx Pharmaceuticals Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 61. Sanofi Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 63. Bayer Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 65. Abbott Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 66. Cipla Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
